Planet Technologies

Planet Biotechnology is a biopharmaceutical company specializing in the development of plant-based therapeutic antibodies and proteins, a technology platform it refers to as "Plantibodies." By utilizing transgenic plants like tobacco (Nicotiana benthamiana) as expression systems, the company aims to produce complex human-like biologics that are more scalable and cost-effective than those produced via traditional mammalian cell cultures. Their lead clinical candidate, CaroRx, is a topical secretory IgA antibody designed to prevent dental caries by targeting the bacteria Streptococcus mutans. Additionally, the company maintains a pipeline of recombinant proteins focused on infectious diseases and biodefense, including treatments for Anthrax and MERS-CoV.